Primary study · included by 1 review

Effect of the addition of Chitosan and TiO <sub>2</sub> nanoparticles on antibacterial properties of an orthodontic composite in fixed orthodontic treatment: a randomized clinical trial study

Farzanegan et al. 2021 · Farzanegan Fahimeh, Shahabi Mostafa, Niazi Ahmad Ehsan, et al. · Biomedical Physics &amp; Engineering Express · 2021

Trial PICO

Not extracted yet. Trial-level population, intervention, comparator, outcomes and design will appear here after the trial extraction run. Until then, the reviews below describe the study.

Results

Not extracted yet. Per-trial results (events, means, effect and weight as each review's forest plot reports them) will appear here after the trial extraction run.

Included by

Can Orthodontic Adhesive Systems Inhibit the Formation and Development of White Spot Lesions During Fixed Orthodontic Treatment? A Systematic Review.
Non-Cochrane · intervention · 2024 · cited as Farzanegan et al. 2021 · Table 1 (Farzanegan 2021); Reference 14
Outcome this study informsPooled effectEvidenceCertainty
Streptococcus mutans count
Transbond XT with 1% chitosan and 1% TiO2 nanoparticles vs Transbond XT adhesive · 1 day, 2 months, and 6 months after bonding
Experimental group: significant decrease in S. mutans count was observed at the time points of 1 day, 2 months, and 6 months for both maxillary lateral incisor (p = 0.01) and maxillary second premolar teeth (p = 0.001).1 study · 24 participantsUngraded
Enamel demineralization / white spot lesion prevention (DIAGNOdent, enamel mineral content)
Farzanegan 2021 = Transbond XT + 1% chitosan + 1% TiO2 (co-intervention); Mollabashi 2022 = TiO2-only composite (1 wt%) vs Conventional adhesive/composite (Transbond XT) · 1 day to 6 months
Two RCTs (Farzanegan 2021 n=24; Mollabashi 2022 n=40): Mollabashi reported DIAGNOdent readings significantly lower on the TiO2 side than the control side (p<0.001); Farzanegan reported no significant difference in…2 studies · 64 participantsUngraded

1 including review in total.